Penumbra Q3 Earnings Beat, Margins Expand, Stock Up in After Market
The third-quarter results reflect another strong performance by Penumbra's U.S. thrombectomy business.
| Ticker |
Sentiment |
Impact |
|
PEN
|
Bullish
|
46 %
|
|
RMD
|
Neutral
|
19 %
|
|
DGX
|
Neutral
|
19 %
|
|
BSX
|
Neutral
|
19 %
|
